The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society

Affiliations

• ¹ 3rd Department of Internal Diseases and Cardiology, Medical University of Warsaw, Warszawa, Poland. anna.mlynarczyk@viamedica.pl.
• ² Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland.
• ³ 3rd Department of Internal Diseases and Cardiology, Medical University of Warsaw, Warszawa, Poland.
• ⁴ Institute of Clinical Sciences, Maria Sklodowska-Curie Medical Academy, Warszawa, Poland.
• ⁵ 1st Department of Cardiology and Electrotherapy, Świętokrzyskie Cardiology Center, Kielce, Poland.
• ⁶ Department of Internal Diseases and Cardiac Rehabilitation, Medical University of Lodz, Łódź, Poland.
• ⁷ Departament of Civilization Diseases, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, Warszawa, Poland.
• ⁸ 1st Chair and Department of Cardiology, Medical University of Lodz, Łódź, Poland.
• ⁹ 1st Chair and Department of Cardiology, Medical University of Warsaw, Warszawa, Poland.
• ¹⁰ Department of Internal Diseases, Medical University of Lublin, Lublin, Poland.